[Advantages and limitations of Triage DOA screening in clinical and forensic drug testing].
Moriya
Fumio
F
D002491:Central Nervous System Agents / Q000009:adverse effects / Q000652:urine; D006801:Humans; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity; D015813:Substance Abuse Detection / Q000379:methods*; D019966:Substance-Related Disorders / Q000175:diagnosis*
D002491:Central Nervous System Agents; D011933:Reagent Kits, Diagnostic